![Bayer AG on Twitter: "Bayer came out on top as the only company on list with "strong" reputation. @businessinsider https://t.co/9En8cYYDRN https://t.co/NL8V8PdQB3" / Twitter Bayer AG on Twitter: "Bayer came out on top as the only company on list with "strong" reputation. @businessinsider https://t.co/9En8cYYDRN https://t.co/NL8V8PdQB3" / Twitter](https://pbs.twimg.com/media/CjtoNZvWYAAp3Nd.jpg:large)
Bayer AG on Twitter: "Bayer came out on top as the only company on list with "strong" reputation. @businessinsider https://t.co/9En8cYYDRN https://t.co/NL8V8PdQB3" / Twitter
![Bayer Ceo Marijn Dekkers Presents Balance Editorial Stock Photo - Stock Image | Shutterstock Editorial Bayer Ceo Marijn Dekkers Presents Balance Editorial Stock Photo - Stock Image | Shutterstock Editorial](https://editorial01.shutterstock.com/preview-440/8230964f/3d41bca2/Shutterstock_8230964f.jpg)
Bayer Ceo Marijn Dekkers Presents Balance Editorial Stock Photo - Stock Image | Shutterstock Editorial
![Werner Baumann to succeed Dr. Marijn Dekkers as Chairman of the Board of Management of Bayer - HealthManagement.org Werner Baumann to succeed Dr. Marijn Dekkers as Chairman of the Board of Management of Bayer - HealthManagement.org](https://res.cloudinary.com/healthmanagement-org/image/upload/f_auto,fl_lossy/v1460023502/cw/00108070_cw_image.jpg)
Werner Baumann to succeed Dr. Marijn Dekkers as Chairman of the Board of Management of Bayer - HealthManagement.org
![Unilever Chair Marijn Dekkers replaced by Nils Anderson following troubled tenure - Global Cosmetics News Unilever Chair Marijn Dekkers replaced by Nils Anderson following troubled tenure - Global Cosmetics News](https://www.globalcosmeticsnews.com/wp-content/uploads/2019/11/marijn-dekkers-cb926276-f97f-4f4f-94d2-a9a08212cef-resize-750.jpeg)
Unilever Chair Marijn Dekkers replaced by Nils Anderson following troubled tenure - Global Cosmetics News
![Marijn Dekkers (L), CEO of Bayer AG and Manfred Schneider, Chairman of Supervisory Board shake hands during the annual general meeting in Cologne April 29, 2011. Bayer plans to spend a combined Marijn Dekkers (L), CEO of Bayer AG and Manfred Schneider, Chairman of Supervisory Board shake hands during the annual general meeting in Cologne April 29, 2011. Bayer plans to spend a combined](https://c8.alamy.com/comp/2E6DFKP/marijn-dekkers-l-ceo-of-bayer-ag-and-manfred-schneider-chairman-of-supervisory-board-shake-hands-during-the-annual-general-meeting-in-cologne-april-29-2011-bayer-plans-to-spend-a-combined-15-billion-euros-223-billion-on-research-and-development-plants-and-equipment-until-2013-its-chief-executive-dekkers-said-reutersalex-domanski-germany-tags-business-2E6DFKP.jpg)
Marijn Dekkers (L), CEO of Bayer AG and Manfred Schneider, Chairman of Supervisory Board shake hands during the annual general meeting in Cologne April 29, 2011. Bayer plans to spend a combined
Interesting encounter - Dr. Marijn Dekkers, Keynote speaker at 1st Pharmaceutical Circle (Fette Compacting GmbH)
Marijn Dekkers email address & phone number | Agriterra Agripooler contact information - RocketReach
![Marijn Dekkers, outgoing CEO of German pharmaceutical and chemical maker Bayer AG poses at the annual general meeting in Cologne, Germany, April 29, 2016. REUTERS/Wolfgang Rattay Stock Photo - Alamy Marijn Dekkers, outgoing CEO of German pharmaceutical and chemical maker Bayer AG poses at the annual general meeting in Cologne, Germany, April 29, 2016. REUTERS/Wolfgang Rattay Stock Photo - Alamy](https://c8.alamy.com/comp/2E6HBDT/marijn-dekkers-outgoing-ceo-of-german-pharmaceutical-and-chemical-maker-bayer-ag-poses-at-the-annual-general-meeting-in-cologne-germany-april-29-2016-reuterswolfgang-rattay-2E6HBDT.jpg)
Marijn Dekkers, outgoing CEO of German pharmaceutical and chemical maker Bayer AG poses at the annual general meeting in Cologne, Germany, April 29, 2016. REUTERS/Wolfgang Rattay Stock Photo - Alamy
![Marijn Dekkers, CEO of Bayer AG poses before the annual general meeting in Cologne April 27, 2012. Bayer's Chief Executive Marijn Dekkers reiterated the group is looking in the healthcare and crop Marijn Dekkers, CEO of Bayer AG poses before the annual general meeting in Cologne April 27, 2012. Bayer's Chief Executive Marijn Dekkers reiterated the group is looking in the healthcare and crop](https://c8.alamy.com/comp/2E661B9/marijn-dekkers-ceo-of-bayer-ag-poses-before-the-annual-general-meeting-in-cologne-april-27-2012-bayers-chief-executive-marijn-dekkers-reiterated-the-group-is-looking-in-the-healthcare-and-crop-science-industries-for-any-takeover-targets-reutersina-fassbender-germany-tags-business-health-2E661B9.jpg)
Marijn Dekkers, CEO of Bayer AG poses before the annual general meeting in Cologne April 27, 2012. Bayer's Chief Executive Marijn Dekkers reiterated the group is looking in the healthcare and crop
![In a recently published interview in Bloomberg Businessweek, Bayer CEO Marijn Dekkers said that his company's cancer drug isn't for poor people. “We did not develop this medicine for Indians…we developed it In a recently published interview in Bloomberg Businessweek, Bayer CEO Marijn Dekkers said that his company's cancer drug isn't for poor people. “We did not develop this medicine for Indians…we developed it](https://external-preview.redd.it/vn4UDkt9xAZXUue2e0b-4Swt_axZSZmElQ0incHZg5Y.jpg?width=640&crop=smart&auto=webp&s=056fb2803a2c1509b5f6b2b201dd8d7d87704482)